Clinical Trials Browser

OTHER × Glioma × olaparib × Clear all

NCT06607692 2026-04-14

LUPARPED

Phase 1/2 Recruiting

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT05188508 2026-03-06

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Phase 2 Recruiting

Glioma

NCT03212742 2025-12-04

OLA-TMZ-RTE-01

Phase 1/2 Active not recruiting

Glioma

NCT03561870 2025-09-12

OLAGLI

Phase 2 Completed

Glioma, Recurrence

NCT03991832 2024-07-18

SOLID

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma